Interpret the laboratory results of a 53‑year‑old woman with mild neutrophilia, eosinophilia, normal renal function, elevated AST (60 U/L), ALT (112 U/L), ALP (309 U/L), GGT (257 U/L), and ferritin 147 µg/L.

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Interpretation: 53-Year-Old Woman with Hepatobiliary Enzyme Elevation and Eosinophilia

This bloodwork reveals a cholestatic pattern of liver injury with markedly elevated alkaline phosphatase (309 U/L) and GGT (257 U/L), accompanied by mild transaminase elevation (AST 60 U/L, ALT 112 U/L), mild eosinophilia (1.00 × 10e9/L), and borderline elevated ferritin (147 µg/L), which together strongly suggest an autoimmune cholestatic liver disease—most likely primary biliary cholangitis (PBC)—requiring immediate serological testing for anti-mitochondrial antibodies (AMA) and anti-nuclear antibodies (ANA). 1

Hepatobiliary Pattern Analysis

Cholestatic Predominance

  • The disproportionate elevation of ALP (309 U/L, >2.8× upper limit) and GGT (257 U/L, >7× upper limit) compared to transaminases defines a cholestatic injury pattern. 2 The GGT:ALP ratio is markedly elevated, which is characteristic of autoimmune cholestatic diseases. 1

  • In early-stage PBC, 29.2% of patients have normal ALP levels, but GGT elevation is more robust—with 29.2% showing GGT >10× upper limit of normal even when ALP is only mildly elevated. 1 This patient's pattern fits this profile precisely.

  • The ALT:AST ratio of approximately 1.9:1 argues against advanced fibrosis or cirrhosis, where the ratio typically inverts to <1. 2 This suggests early-stage disease.

Critical Next Steps for Liver Disease Evaluation

Order the following autoimmune liver disease panel immediately: 2

  • Anti-mitochondrial antibody (AMA) and AMA-M2: Detection rate of 66.7% and 45.8% respectively in early-stage PBC 1
  • Anti-nuclear antibody (ANA): When AMA/AMA-M2 are negative, ANA positivity reaches 92.3% in early PBC, with ANA centromere pattern being most common (38.5%) 1
  • Anti-smooth muscle antibody and serum immunoglobulins: To evaluate for autoimmune hepatitis overlap 2
  • Anti-LKM antibody: For type 2 autoimmune hepatitis 2

Hematologic Findings

Eosinophilia Interpretation

  • The absolute eosinophil count of 1.00 × 10e9/L (reference 0.00-0.30) represents significant eosinophilia that requires investigation. 2 In the context of liver disease, this raises three primary considerations:
  1. Drug-induced liver injury with hypersensitivity: Review all medications, particularly antibiotics, NSAIDs, and herbal supplements
  2. Parasitic infection: Consider strongyloidiasis, toxocariasis, or other helminthic infections, especially with travel history
  3. Autoimmune hepatitis: Eosinophilia can accompany autoimmune liver disease 3

Mild Neutrophilia

  • The neutrophil count of 6.10 × 10e9/L (reference 2.00-6.00) represents borderline elevation. 4 Women typically have neutrophil counts 0.66 × 10e9/L higher than men, and afternoon sampling can add another 0.50 × 10e9/L. 4 This mild elevation is likely physiologic or reactive to inflammation rather than pathologic.

Normal Complete Blood Count

  • The hemoglobin (148 g/L), hematocrit (0.450 L/L), and RBC indices are all normal, excluding anemia as a contributor to the clinical picture. 2

Iron Studies Interpretation

Borderline Elevated Ferritin with Normal Iron Parameters

The ferritin of 147 µg/L (reference 20-120) is mildly elevated, but iron saturation (37%) and TIBC (60 µmol/L) are both normal, indicating this is NOT iron overload. 5, 6

  • Ferritin is an acute-phase reactant that rises with inflammation, infection, and liver disease. 2, 6 In the context of elevated liver enzymes and possible autoimmune disease, this ferritin elevation reflects inflammation rather than iron excess.

  • The normal transferrin saturation (37%, reference 14-51%) definitively excludes hemochromatosis or significant iron overload. 3 In true iron overload, transferrin saturation typically exceeds 45-50%. 5

  • This pattern (mildly elevated ferritin with normal iron saturation) is characteristic of inflammatory liver disease, not iron storage disease. 3 Autoimmune hepatitis can present with elevated ferritin and transferrin saturation that mimics iron overload, but liver biopsy distinguishes these entities. 3

Differential Diagnosis Priority

Primary Biliary Cholangitis (Most Likely)

The combination of marked GGT elevation (>7× ULN), disproportionate to ALP elevation, in a 53-year-old woman strongly suggests early-stage PBC. 1 The absence of jaundice (normal bilirubin implied by chemistry panel) and normal albumin indicate early disease before cirrhosis develops. 1

Adult-Onset Still's Disease (Less Likely but Consider)

  • While ferritin is elevated, it is not in the extreme range (>5000 ng/mL) typical of AOSD. 2, 7 AOSD with hemophagocytic syndrome shows mean ferritin of 18,179 ng/mL. 7
  • The absence of fever, rash, and arthritis documented in the clinical context makes AOSD unlikely. 2
  • Eosinophilia is not a typical feature of AOSD, which more commonly shows neutrophilia. 2

Drug-Induced Liver Injury

  • The eosinophilia raises concern for drug-induced hypersensitivity hepatitis. 3 Obtain detailed medication history including over-the-counter drugs and supplements.

Recommended Diagnostic Algorithm

Immediate Laboratory Testing

  1. Autoimmune liver panel: AMA, AMA-M2, ANA (with reflex to specific patterns including centromere), anti-smooth muscle antibody, serum IgM and IgG 2, 1
  2. Viral hepatitis serologies: Hepatitis B surface antigen, hepatitis C antibody with reflex PCR 2
  3. Stool ova and parasites (×3 specimens): To evaluate eosinophilia 2
  4. Comprehensive metabolic panel: If not already complete, to assess bilirubin and albumin 2

Imaging

  • Abdominal ultrasound: To evaluate for biliary obstruction, hepatomegaly, and exclude structural causes of cholestasis 2

Follow-Up Based on Results

  • If AMA/AMA-M2 positive: Diagnosis of PBC is confirmed; proceed to liver biopsy for staging 1
  • If AMA/AMA-M2 negative but ANA positive (especially centromere pattern): PBC remains likely; liver biopsy is diagnostic 1
  • If all autoimmune markers negative: Consider liver biopsy to evaluate for drug-induced injury, eosinophilic infiltration, or other causes 3

Clinical Pitfalls to Avoid

  • Do not attribute the elevated ferritin to iron overload when transferrin saturation is normal. 3 This is a common error that delays diagnosis of the underlying inflammatory liver disease.

  • Do not dismiss PBC when ALP is only moderately elevated if GGT is markedly elevated. 1 Early PBC shows disproportionate GGT elevation.

  • Do not overlook ANA testing when AMA is negative. 1 ANA-positive, AMA-negative PBC accounts for a significant minority of cases and has similar prognosis.

  • Do not ignore the eosinophilia. 2 While it may be reactive to liver disease, parasitic infection and drug hypersensitivity must be excluded.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Autoimmune Hepatitis: Diagnostic Dilemma When It Is Disguised as Iron Overload Syndrome.

Journal of clinical and experimental hepatology, 2017

Guideline

Iron Deficiency Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Iron Deficiency Anemia with Normal Ferritin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the workup for a 39-year-old male with leukopenia (white blood cell count of 3.9), lymphocytosis (51% lymphocyte predominance), and a small neck mass?
Which of the following findings support the diagnosis of primary biliary cholangitis?
What is the next step in managing a 57-year-old female with elevated Aspartate Aminotransferase (AST) and Alanine Aminotransferase (ALT) levels, normal Gamma-Glutamyl Transferase (GGT) and Alkaline Phosphatase (ALP) levels?
What is the appropriate management for a 24-year-old female patient with normal CBC, iron, ferritin, and TSH levels, but elevated TIBC, slightly elevated alkaline phosphatase, and mildly elevated creatinine, indicating impaired renal function?
What is the next step in managing a 24-year-old male with elevated alkaline phosphatase (ALP), normal aspartate aminotransferase (AST) and alanine aminotransferase (ALT), mild hypoglycemia, and a history of recent gastrointestinal viral illness, smoking, and moderate alcohol use?
Are facial spider veins telangiectasias?
For an 80‑kg older adult with type 2 diabetes who developed urinary tract infections while on an SGLT2 inhibitor, how should his antihyperglycemic regimen be adjusted?
What is the most appropriate initial management for a 55-year-old woman with metastatic breast cancer and severe hypercalcemia presenting with nausea, confusion, and muscle weakness?
What is the differential diagnosis and initial work‑up for a 60‑year‑old female with isolated right‑sided abdominal pain without nausea, vomiting or back pain?
Given the patient is taking lis‑dexamfetamine (Vyvanse) 70 mg each morning, vitamin D 50 000 IU weekly, venlafaxine (Effexor) 225 mg daily, and trazodone 50 mg at bedtime, which medication should be added to achieve rapid anxiety control?
In a post‑stroke patient with arm edema, reduced proprioception and mild spasticity but intact skin and good arterial flow, is a soft elastic arm compression sleeve indicated, and what are the recommended application method, duration and precautions?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.